Emergent Biosolutions Inc’s recently made public that its Director DeGolyer Donald W unloaded Company’s shares for reported $0.27 million on Nov 12 ’24. In the deal valued at $10.91 per share,25,000 shares were sold. As a result of this transaction, DeGolyer Donald W now holds 111,100 shares worth roughly $1.12 million.
Then, White Marvin L sold 14,287 shares, generating $171,015 in total proceeds. Upon selling the shares at $11.97, the Director now owns 54,092 shares.
Before that, DeGolyer Donald W bought 25,000 shares. Emergent Biosolutions Inc shares valued at $294,250 were divested by the Director at a price of $11.77 per share.
H.C. Wainwright initiated its Emergent Biosolutions Inc [EBS] rating to a Buy in a research note published on December 30, 2024; the price target was $15. A number of analysts have revised their coverage, including Rodman & Renshaw’s analysts, who began to cover the stock in late August with a ‘”a Buy”‘ rating. The Benchmark Company also remained covering EBS and has increased its forecast on March 07, 2024 with a “Buy” recommendation from previously “Hold” rating.
Price Performance Review of EBS
On Monday, Emergent Biosolutions Inc [NYSE:EBS] saw its stock jump 1.10% to $10.11. Over the last five days, the stock has lost -3.62%. Emergent Biosolutions Inc shares have risen nearly 5.75% since the year began. Nevertheless, the stocks have risen 574.00% over the past one year. While a 52-week high of $15.10 was reached on 01/24/25, a 52-week low of $1.48 was recorded on 01/16/25. SMA at 50 days reached $9.71, while 200 days put it at $8.38.
Levels Of Support And Resistance For EBS Stock
The 24-hour chart illustrates a support level at 9.91, which if violated will result in even more drops to 9.71. On the upside, there is a resistance level at 10.40. A further resistance level may holdings at 10.69. The Relative Strength Index (RSI) on the 14-day chart is 47.66, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.67, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 90.78%. Stochastics %K at 15.22% indicates the stock is a buying.
How much short interest is there in Emergent Biosolutions Inc?
A steep rise in short interest was recorded in Emergent Biosolutions Inc stocks on 2025-01-15, growing by 0.1 million shares to a total of 7.04 million shares. Yahoo Finance data shows the prior-month short interest on 2024-12-13 was 6.94 million shares. There was a rise of 1.47%, which implies that there is a positive sentiment for the stock.
